Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients

Elio Roti, Lewis E. Braverman, Giuseppe Robuschi, Mario Salvi, Eliana Gardini, Lorenzo d'Amato, Dante Maestri, Mara Montermini, Elisabetta Borciani, Antonio Pezzarossa, Paolo Chiodera, Attilio Manfredi, Ronald A. Arky, Angelo Gnudi

Research output: Contribution to journalArticle

Abstract

The effect of oral glucose and arginine infusion on plasma glucose, glucagon, serum insulin, and C-peptide concentrations was evaluated in 16 patients with hyperthyroid Graves' disease and in ten euthyroid age- and sex-matched normal subjects. Basal plasma glucose concentrations were significantly higher in the hyperthyroid patients, but the plasma glucose response following glucose and arginine administration was similar in the two groups. The insulin response was similar in the hyperthyroid and normal subjects after glucose administration and significantly lower during arginine infusion in the hyperthyroid patients. The serum C-peptide response to both glucose and arginine administration was markedly blunted in the hyperthyroid patients, and the plasma glucagon response to arginine infusion was decreased. These results suggest that pancreatic beta and alpha cell secretory function is impaired in hyperthyroidism as assessed by C-peptide and glucagon secretion following oral glucose administration and arginine infusion. The apparent discrepancy between C-peptide and insulin secretion in the hyperthyroid patients following glucose administration might be due to diminished hepatic extraction of insulin or enhanced metabolism of C-peptide.

Original languageEnglish
Pages (from-to)337-342
Number of pages6
JournalMetabolism
Volume35
Issue number4
DOIs
Publication statusPublished - 1986

Fingerprint

C-Peptide
Hyperthyroidism
Glucagon
Arginine
Insulin
Glucose
Serum
Glucagon-Secreting Cells
Graves Disease
Insulin-Secreting Cells
Oral Administration
Liver

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients. / Roti, Elio; Braverman, Lewis E.; Robuschi, Giuseppe; Salvi, Mario; Gardini, Eliana; d'Amato, Lorenzo; Maestri, Dante; Montermini, Mara; Borciani, Elisabetta; Pezzarossa, Antonio; Chiodera, Paolo; Manfredi, Attilio; Arky, Ronald A.; Gnudi, Angelo.

In: Metabolism, Vol. 35, No. 4, 1986, p. 337-342.

Research output: Contribution to journalArticle

Roti, E, Braverman, LE, Robuschi, G, Salvi, M, Gardini, E, d'Amato, L, Maestri, D, Montermini, M, Borciani, E, Pezzarossa, A, Chiodera, P, Manfredi, A, Arky, RA & Gnudi, A 1986, 'Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients', Metabolism, vol. 35, no. 4, pp. 337-342. https://doi.org/10.1016/0026-0495(86)90151-4
Roti, Elio ; Braverman, Lewis E. ; Robuschi, Giuseppe ; Salvi, Mario ; Gardini, Eliana ; d'Amato, Lorenzo ; Maestri, Dante ; Montermini, Mara ; Borciani, Elisabetta ; Pezzarossa, Antonio ; Chiodera, Paolo ; Manfredi, Attilio ; Arky, Ronald A. ; Gnudi, Angelo. / Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients. In: Metabolism. 1986 ; Vol. 35, No. 4. pp. 337-342.
@article{3baf1c2bc4a3418daa43f49a8ec9075f,
title = "Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients",
abstract = "The effect of oral glucose and arginine infusion on plasma glucose, glucagon, serum insulin, and C-peptide concentrations was evaluated in 16 patients with hyperthyroid Graves' disease and in ten euthyroid age- and sex-matched normal subjects. Basal plasma glucose concentrations were significantly higher in the hyperthyroid patients, but the plasma glucose response following glucose and arginine administration was similar in the two groups. The insulin response was similar in the hyperthyroid and normal subjects after glucose administration and significantly lower during arginine infusion in the hyperthyroid patients. The serum C-peptide response to both glucose and arginine administration was markedly blunted in the hyperthyroid patients, and the plasma glucagon response to arginine infusion was decreased. These results suggest that pancreatic beta and alpha cell secretory function is impaired in hyperthyroidism as assessed by C-peptide and glucagon secretion following oral glucose administration and arginine infusion. The apparent discrepancy between C-peptide and insulin secretion in the hyperthyroid patients following glucose administration might be due to diminished hepatic extraction of insulin or enhanced metabolism of C-peptide.",
author = "Elio Roti and Braverman, {Lewis E.} and Giuseppe Robuschi and Mario Salvi and Eliana Gardini and Lorenzo d'Amato and Dante Maestri and Mara Montermini and Elisabetta Borciani and Antonio Pezzarossa and Paolo Chiodera and Attilio Manfredi and Arky, {Ronald A.} and Angelo Gnudi",
year = "1986",
doi = "10.1016/0026-0495(86)90151-4",
language = "English",
volume = "35",
pages = "337--342",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients

AU - Roti, Elio

AU - Braverman, Lewis E.

AU - Robuschi, Giuseppe

AU - Salvi, Mario

AU - Gardini, Eliana

AU - d'Amato, Lorenzo

AU - Maestri, Dante

AU - Montermini, Mara

AU - Borciani, Elisabetta

AU - Pezzarossa, Antonio

AU - Chiodera, Paolo

AU - Manfredi, Attilio

AU - Arky, Ronald A.

AU - Gnudi, Angelo

PY - 1986

Y1 - 1986

N2 - The effect of oral glucose and arginine infusion on plasma glucose, glucagon, serum insulin, and C-peptide concentrations was evaluated in 16 patients with hyperthyroid Graves' disease and in ten euthyroid age- and sex-matched normal subjects. Basal plasma glucose concentrations were significantly higher in the hyperthyroid patients, but the plasma glucose response following glucose and arginine administration was similar in the two groups. The insulin response was similar in the hyperthyroid and normal subjects after glucose administration and significantly lower during arginine infusion in the hyperthyroid patients. The serum C-peptide response to both glucose and arginine administration was markedly blunted in the hyperthyroid patients, and the plasma glucagon response to arginine infusion was decreased. These results suggest that pancreatic beta and alpha cell secretory function is impaired in hyperthyroidism as assessed by C-peptide and glucagon secretion following oral glucose administration and arginine infusion. The apparent discrepancy between C-peptide and insulin secretion in the hyperthyroid patients following glucose administration might be due to diminished hepatic extraction of insulin or enhanced metabolism of C-peptide.

AB - The effect of oral glucose and arginine infusion on plasma glucose, glucagon, serum insulin, and C-peptide concentrations was evaluated in 16 patients with hyperthyroid Graves' disease and in ten euthyroid age- and sex-matched normal subjects. Basal plasma glucose concentrations were significantly higher in the hyperthyroid patients, but the plasma glucose response following glucose and arginine administration was similar in the two groups. The insulin response was similar in the hyperthyroid and normal subjects after glucose administration and significantly lower during arginine infusion in the hyperthyroid patients. The serum C-peptide response to both glucose and arginine administration was markedly blunted in the hyperthyroid patients, and the plasma glucagon response to arginine infusion was decreased. These results suggest that pancreatic beta and alpha cell secretory function is impaired in hyperthyroidism as assessed by C-peptide and glucagon secretion following oral glucose administration and arginine infusion. The apparent discrepancy between C-peptide and insulin secretion in the hyperthyroid patients following glucose administration might be due to diminished hepatic extraction of insulin or enhanced metabolism of C-peptide.

UR - http://www.scopus.com/inward/record.url?scp=0022527341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022527341&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(86)90151-4

DO - 10.1016/0026-0495(86)90151-4

M3 - Article

C2 - 3515118

AN - SCOPUS:0022527341

VL - 35

SP - 337

EP - 342

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 4

ER -